Moneycontrol PRO
you are here: HomeNewsWorld

Explained: What we know about Japan's contaminated Moderna COVID-19 vaccine supplies

Japan's COVID-19 vaccination push has been dealt a blow by widening reports of contamination in supplies of Moderna Inc's COVID-19 vaccine.

August 30, 2021 / 02:08 PM IST
US vaccine maker Moderna exceeded Wall Street's expectations reaping windfall in the second quarter ended June 31.

US vaccine maker Moderna exceeded Wall Street's expectations reaping windfall in the second quarter ended June 31.

Japan's COVID-19 vaccination push has been dealt a blow by widening reports of contamination in supplies of Moderna Inc's COVID-19 vaccine.

Here are some key points in the issue so far.

WHEN WAS IT FIRST REPORTED AND HOW HAS IT WIDENED?

On August 16, the first contamination was reported to Takeda Pharmaceutical Co, Moderna's local distributor.

That led to the discovery of 39 vials containing foreign material in them, all from the same lot of 57,000 vials or about 570,000 doses.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

On Aug. 26, Japan said it had halted the use of 1.63 million Moderna doses shipped to 863 vaccination centres nationwide as a precaution.

It suspended the use of lot 3004667 that included those vials and two similarly sized lots - 3004734 and 3004956.

On Sunday, a vaccination centre in Okinawa prefecture reported that contaminants were found in Moderna vials from a fourth lot 3005293.

Black substances were spotted in syringes and a vial, while pink substances were found in a different syringe, the health ministry said.

Also on Sunday, Gunma prefecture, near Tokyo, found a tiny, black substance in a Moderna vial, which differed from the four already suspended. The Gunma lot, whose number has not yet been disclosed, was also suspended.

Following the two Sunday incidents, the use of about 1 million additional doses have been suspended.

WHAT ARE THE CONTAMINANTS?

The contaminants are believed to be metallic particles, public broadcaster NHK reported, citing health ministry sources.

The ministry has not officially said what the particles are, pending an investigation by Takeda, Moderna, and its Spanish contract manufacturing partner Rovi. Those companies have also yet to comment on what the foreign material is.

IS THERE A SAFETY ISSUE?

Japan and Moderna have said no safety issues had been identified.

Two men, aged 38 and 30, died this month within days of receiving their second Moderna doses, the health ministry said on Saturday. Each had one shot from one of the suspended lots, 3004734. The causes of death are being investigated.

Both men had a fever the day after their second dose and died two days after getting the fever. There has been no evidence that their shots contained contaminants, a health ministry official told reporters.

As of Aug. 8, 991 people had died in Japan after receiving COVID-19 shots from Pfizer/BioNTech, and 11 after receiving Moderna's. No causality between the injections and the deaths has been established, according to the health ministry.

About 500,000 people have gotten shots from the first three suspended batches, Taro Kono, the minister in charge of the vaccine push, told reporters on Friday.

ARE OTHER COUNTRIES ALSO AFFECTED?

Rovi, which bottles Moderna vaccines for markets other than the United States, said last week the batch in question was meant for distribution only in Japan.

South Korea, which also receives the Moderna vaccines produced from sites in the United States and Spain, said it was not affected by the issue.

The European Union drugs regulator said last week it was investigating the incident but did not find reasons to seek a temporary suspension of production after an initial assessment.
Reuters
first published: Aug 30, 2021 02:08 pm
Sections
ISO 27001 - BSI Assurance Mark